ANIP
Price
$92.98
Change
-$0.39 (-0.42%)
Updated
Sep 26, 03:13 PM (EDT)
Capitalization
2.03B
40 days until earnings call
ORGO
Price
$4.08
Change
-$0.61 (-13.03%)
Updated
Sep 26, 04:44 PM (EDT)
Capitalization
593.69M
40 days until earnings call
Interact to see
Advertisement

ANIP vs ORGO

Header iconANIP vs ORGO Comparison
Open Charts ANIP vs ORGOBanner chart's image
ANI Pharmaceuticals
Price$92.98
Change-$0.39 (-0.42%)
Volume$100
Capitalization2.03B
Organogenesis Holdings
Price$4.08
Change-$0.61 (-13.03%)
Volume$8.2K
Capitalization593.69M
ANIP vs ORGO Comparison Chart in %
Loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIP vs. ORGO commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIP is a StrongBuy and ORGO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ANIP: $93.37 vs. ORGO: $4.68)
Brand notoriety: ANIP and ORGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ANIP: 42% vs. ORGO: 61%
Market capitalization -- ANIP: $2.03B vs. ORGO: $593.69M
ANIP [@Pharmaceuticals: Generic] is valued at $2.03B. ORGO’s [@Pharmaceuticals: Generic] market capitalization is $593.69M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIP’s FA Score shows that 1 FA rating(s) are green whileORGO’s FA Score has 1 green FA rating(s).

  • ANIP’s FA Score: 1 green, 4 red.
  • ORGO’s FA Score: 1 green, 4 red.
According to our system of comparison, both ANIP and ORGO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIP’s TA Score shows that 4 TA indicator(s) are bullish while ORGO’s TA Score has 4 bullish TA indicator(s).

  • ANIP’s TA Score: 4 bullish, 4 bearish.
  • ORGO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ANIP and ORGO are a good buy in the short-term.

Price Growth

ANIP (@Pharmaceuticals: Generic) experienced а -4.22% price change this week, while ORGO (@Pharmaceuticals: Generic) price change was -1.47% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.63%. For the same industry, the average monthly price growth was +25.30%, and the average quarterly price growth was +68.14%.

Reported Earning Dates

ANIP is expected to report earnings on Nov 05, 2025.

ORGO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.63% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANIP($2.03B) has a higher market cap than ORGO($594M). ORGO has higher P/E ratio than ANIP: ORGO (63.75) vs ANIP (49.06). ANIP YTD gains are higher at: 68.904 vs. ORGO (46.250). ANIP has higher annual earnings (EBITDA): 89M vs. ORGO (3.19M). ANIP has more cash in the bank: 224M vs. ORGO (73.1M). ORGO has less debt than ANIP: ORGO (40.8M) vs ANIP (622M). ANIP has higher revenues than ORGO: ANIP (747M) vs ORGO (429M).
ANIPORGOANIP / ORGO
Capitalization2.03B594M341%
EBITDA89M3.19M2,789%
Gain YTD68.90446.250149%
P/E Ratio49.0663.7577%
Revenue747M429M174%
Total Cash224M73.1M306%
Total Debt622M40.8M1,525%
FUNDAMENTALS RATINGS
ANIP vs ORGO: Fundamental Ratings
ANIP
ORGO
OUTLOOK RATING
1..100
7380
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
2497
SMR RATING
1..100
9395
PRICE GROWTH RATING
1..100
4042
P/E GROWTH RATING
1..100
9510
SEASONALITY SCORE
1..100
n/a65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORGO's Valuation (75) in the Financial Conglomerates industry is in the same range as ANIP (94) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to ANIP’s over the last 12 months.

ANIP's Profit vs Risk Rating (24) in the Pharmaceuticals Other industry is significantly better than the same rating for ORGO (97) in the Financial Conglomerates industry. This means that ANIP’s stock grew significantly faster than ORGO’s over the last 12 months.

ANIP's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as ORGO (95) in the Financial Conglomerates industry. This means that ANIP’s stock grew similarly to ORGO’s over the last 12 months.

ANIP's Price Growth Rating (40) in the Pharmaceuticals Other industry is in the same range as ORGO (42) in the Financial Conglomerates industry. This means that ANIP’s stock grew similarly to ORGO’s over the last 12 months.

ORGO's P/E Growth Rating (10) in the Financial Conglomerates industry is significantly better than the same rating for ANIP (95) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew significantly faster than ANIP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIPORGO
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 23 days ago
74%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TWIEX13.97N/A
N/A
American Century International Gr Inv
SESLX33.07N/A
N/A
1919 Socially Responsive Balanced C
TIBAX31.63-0.10
-0.32%
Thornburg Investment Income Builder A
APDNX18.17-0.11
-0.60%
Artisan Select Equity Advisor
RYTNX382.78-3.89
-1.01%
Rydex S&P 500 2x Strategy H

ANIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with ORGO. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then ORGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
-1.71%
ORGO - ANIP
48%
Loosely correlated
-4.49%
AMRX - ANIP
35%
Loosely correlated
-1.13%
DRRX - ANIP
34%
Loosely correlated
N/A
PRGO - ANIP
33%
Poorly correlated
-2.95%
COLL - ANIP
32%
Poorly correlated
-1.45%
More

ORGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with ANIP. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then ANIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
-4.49%
ANIP - ORGO
49%
Loosely correlated
-1.71%
PRGO - ORGO
46%
Loosely correlated
-2.95%
ANIK - ORGO
33%
Poorly correlated
-0.77%
GTBIF - ORGO
29%
Poorly correlated
-7.42%
AMRX - ORGO
29%
Poorly correlated
-1.13%
More